ElmerYChangMDPhD

Esophagus Disease, Gastrointestinal Cancer, Inflammatory Bowel Disease

Physician

Dr. Chang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
27871 Medical Center Rd
Suite 200
Mission Viejo, CA 92691
Phone+1 949-364-5090

Fax+1 949-542-8710

University of California (San Francisco)Fellowship, Gastroenterology, 2007 - 2008
UCLAPhD, Microbiology, immunology, and molecular genetics, 2003 - 2007
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 2001 - 2007
Baylor College of MedicineResidency, Internal Medicine, 1998 - 2001
Northwestern University The Feinberg School of MedicineClass of 1998

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2013
CCFA research fellowship award Crohn's and Colitis Foundation of America, 2004-2007
Wyeth fellow in digestive diseases UCLA Medical Center, 2002-2004
NIH gastroenterology training grant National Institute of Health, 2002-2004
Specialty training and advanced research fellowship award UCLA, 2001-2007
Medical student research grant Northwestern University Feinberg School of Medicine, 1995
Join now to see all

PubMed

294 citations
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice
Beichu Guo, Elmer Y. Chang, Genhong Cheng
The Journal of Clinical Investigation. 2008-05-01
176 citations
Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production
Elmer Y. Chang, Beichu Guo, Sean E. Doyle, Genhong Cheng
Journal of Immunology. 2007-06-01
71 citations
Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells.
David Q. Shih, Lola Y. Kwan, Valerie Chavez, Offer Cohavy, Rivkah Gonsky
European Journal of Immunology. 2009-11-01

Abstracts/Posters

Serial stricture dilation without pancreatic stenting is a safe and effective therapeutic strategy for the management of chronic pancreatitis-associated pancreatic duc...
Chang EY, Begatelos KC, Buxbaum J, Niho H, Ostroff JW, Gastroenterology, 2008
Inoperable pancreatic cancer patients receiving contemporary chemotherapeutic regimens who have prolonged survival exhibit an increased risk of metal stent occlusion a...
Buxbaum J, Bagatelos KC, Chang EY, Niho H, Ostroff JW, Gastroenterology, 2008
Mechanism of induction of inflammatory bowel disease associated gene TL1A (TNFSF15) by microbes in antigen presenting cells.
Shin DQ, Kwan LY, Chang EY, Chang C, Saruta M, Cohavy O, Elson CO, Targan SR, Gastroenterology, 2008
Crypt cell apoptosis and increased mucosal permeability induced by activated T cells.
Alnadjim Z, Koehler R, Kayali Z, Efthimiou P, Hurst S, Mandrea S, Chang E, Green D, Lin T, Barrett TA, Gastroenterology, 1998
Novel pathway for activation-induced T cell trafficking to the intestine mediated by CD40 ligand and IL-12.
Chiu TT, Bloom R, Chang E, Hurst SD, Barrett TA, Gastroenterology, 1996
Join now to see all